搜索临床试验以:hrIL-2安慰剂
总计66889个结果
-
Merit E. Cudkowicz, MDCalico Life Sciences LLC邀请报名
-
CellSight Technologies, Inc.University of California, San Francisco招聘中
-
Zealand PharmaProfil Institut für Stoffwechselforschung GmbH招聘中
-
Hengenix Biotech Inc完全的
-
CellSight Technologies, Inc.National Institute of Allergy and Infectious Diseases (NIAID); University of California, San...招聘中
-
Universidade Nova de Lisboa招聘中
-
McMaster UniversityNatural Sciences and Engineering Research Council, Canada邀请报名
-
NovavaxDepartment of Health and Human Services完全的
-
National Cancer Institute (NCI)完全的
-
University of North Carolina, Chapel HillNational Institute on Drug Abuse (NIDA)完全的
-
King's College LondonGuy's and St Thomas' NHS Foundation Trust; University of Liverpool; Universidad Veracruzana完全的
-
Sinovac Research and Development Co., Ltd.主动,不招人
-
City of Hope Medical CenterNational Cancer Institute (NCI)招聘中
-
Astellas Pharma IncAstellas Pharma US, Inc.终止
-
GeoVax, Inc.National Cancer Institute (NCI); City of Hope Medical Center主动,不招人
-
University of WashingtonNational Cancer Institute (NCI)终止
-
Roswell Park Cancer Institute撤销
-
Butantan Institute尚未招聘心血管疾病 | 新冠肺炎 | 糖尿病 | 癌症 | 慢性阻塞性肺疾病 | 化疗 | 免疫抑制 | 肾病 | 肾移植的其他并发症巴西
-
Sanofi Pasteur, a Sanofi CompanyGlaxoSmithKline完全的新冠肺炎洪都拉斯, 美国, 澳大利亚, 法国, 新西兰, 西班牙, 英国
-
University of Baghdad招聘中